ECOR
electroCore, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$9.21
+0.00%Year over year
Reported trailing growth
- Revenue
- +33.5%
- EBITDA
- -1.1%
- EBIT
- -6.6%
- EPS
- -3.0%
- Free cash flow
- -27.3%
- Operating cash flow
- -28.2%
Forward estimates
Based on analyst estimates
- Revenue
- +27.4%
- EBITDA
- +34.1%
- EPS
- +39.3%
Three-year CAGR
- Revenue
- +55.1%
- EBITDA
- -9.1%
- EBIT
- -8.1%
- Net income
- -17.5%
- EPS
- -3.8%
- Free cash flow
- -18.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026